靶点- |
|
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of colorectal cancer.
High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of pancreatic cancer.
High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
The aim of this study is the safety and efficacy of high-activity natural killer immunotherapy to small metastases of non-small cell lung cancer.
100 项与 深圳市汉科生物工程有限公司 相关的临床结果
0 项与 深圳市汉科生物工程有限公司 相关的专利(医药)
100 项与 深圳市汉科生物工程有限公司 相关的药物交易
100 项与 深圳市汉科生物工程有限公司 相关的转化医学